 Etidronate hypercalcemia malignancy osteoporosis biphosphonates effective agents treatment metabolic bone diseases Etidronate disodium biphosphonate Food Drug Administration indications etidronate therapy symptomatic Paget disease heterotopic ossification hypercalcemia malignancy unapproved successful use treatment postmenopausal osteoporosis oral intravenous preparations available Newer biphosphonates efficacious toxic etidronate